Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Chris Wallick, Ning Wu, Tu My To, Daniel Keebler & Dalia Moawad. (2021) Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs. Journal of Medical Economics 24:1, pages 386-393.
Read now
Read now
Anita J. Brogan, Sandra E. Talbird, Ashley E. Davis, Edward W. Thommes & Genevieve Meier. (2017) Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach. Human Vaccines & Immunotherapeutics 13:3, pages 533-542.
Read now
Read now
Sangsang Qiu, Ye Shen, Hongqiu Pan, Jianming Wang & Qun Zhang. (2015) Effectiveness and safety of oseltamivir for treating influenza: an updated meta-analysis of clinical trials. Infectious Diseases 47:11, pages 808-819.
Read now
Read now
Patricia Schirmer & Mark Holodniy. (2009) Oseltamivir for treatment and prophylaxis of influenza infection. Expert Opinion on Drug Safety 8:3, pages 357-371.
Read now
Read now
Articles from other publishers (20)
August Wrotek, Oliwia Wrotek & Teresa Jackowska. (2023) Platelet Abnormalities in Children with Laboratory-Confirmed Influenza. Diagnostics 13:4, pages 634.
Crossref
Crossref
Kyeong Hyang Byeon, Jaiyong Kim, Bo Youl Choi, Jin Yong Kim & Nakyoung Lee. (2020) Factors Affecting the Incidence of Hospitalized Pneumonia after Influenza Infection in Korea Using the National Health Insurance Research Database, 2014–2018: Focusing on the Effect of Antiviral Therapy in the 2017 Flu Season. Journal of Korean Medical Science 35:38.
Crossref
Crossref
Zhihao Zhuo, Jin Wang, Wendi Chen, Xiaosong Su, Mengyuan Chen, Mujin Fang, Shuizhen He, Shiyin Zhang, Shengxiang Ge, Jun Zhang & Ningshao Xia. (2018) A Rapid On-Site Assay for the Detection of Influenza A by Capillary Convective PCR. Molecular Diagnosis & Therapy 22:2, pages 225-234.
Crossref
Crossref
Laure-Anne Van Bellinghen, Alen Marijam, Gabriela Tannus Branco de Araujo, Jorge Gomez & Ilse Van Vlaenderen. (2018) Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil – comparison of outcomes from different static model types. The Brazilian Journal of Infectious Diseases 22:1, pages 1-10.
Crossref
Crossref
Sudhir Venkatesan, Puja R. Myles, Jo Leonardi-Bee, Stella G. Muthuri, Malak Al Masri, Nick Andrews, Carlos Bantar, Gal Dubnov-Raz, Patrick Gérardin, Evelyn S. C. Koay, Tze Ping Loh, Ziad Memish, Elizabeth Miller, Maria E. Oliva, Barbara A. Rath, Brunhilde Schweiger, Julian W. Tang, Dat Tran, Tjasa Vidmar, Pauline A. Waight & Jonathan S. Nguyen-Van-Tam. (2017) Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis. Clinical Infectious Diseases 64:10, pages 1328-1334.
Crossref
Crossref
Chang-Bi Wang, Mu-Lin Chiu, Po-Chang Lin, Wen-Miin Liang, Chiu-Ying Chen, Yu-Jun Chang, Trong-Neng Wu, Jen-Hsien Wang & Fung-Chang Sung. (2015) Prompt Oseltamivir Therapy Reduces Medical Care and Mortality for Patients With Influenza Infection. Medicine 94:27, pages e1070.
Crossref
Crossref
Yunping Peng, Junlin Wu, Xiaoyun Liu, Jihua Wang & Wenmei Li. (2013) Evaluation of Wondfo influenza A&B fast test based on immunochromatography assay for rapid diagnosis of influenza A H1N1. The Brazilian Journal of Infectious Diseases 17:2, pages 247-250.
Crossref
Crossref
Charles R. Beck, Rachel Sokal, Nachiappan Arunachalam, Richard Puleston, Anna Cichowska, Anthony Kessel, Maria Zambon & Jonathan S. Nguyen‐Van‐Tam. (2012) Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic. Influenza and Other Respiratory Viruses 7:s1, pages 14-24.
Crossref
Crossref
Magda Abd Elsalam Ahmed, Nabil Jergis Awadalla & Abdel baset Mohamed Saleh. (2011) Clinical epidemiology comparison of H1N1 RT-PCR-positive and RT-PCR-negative pneumonia during the 2009-2010 pandemic in Mansoura University Hospitals, Egypt. Influenza and Other Respiratory Viruses 5:4, pages 241-246.
Crossref
Crossref
A. Rodriguez, E. Diaz, I. Martin-Loeches, A. Sandiumenge, L. Canadell, J. J. Diaz, J. C. Figueira, A. Marques, F. Alvarez-Lerma, J. Valles, B. Baladin, F. Garcia-Lopez, B. Suberviola, R. Zaragoza, S. Trefler, J. Bonastre, J. Blanquer, J. Rello, P. Cobo, J. Martins, C. Carbayo, E. Robles-Musso, A. Cardenas, J. Fierro, D. O. Fernandez, R. Sierra, M. {a. } Jesus Huertos, J. Carlos Pozo, R. Guerrero, E. Marquez, M. Rodriguez-Carvajal, A. Jareno, J. Pomares, J. L. Ballesteros, Y. Fernandez, F. Lobato, J. F. Prieto, J. Albofedo-Sanchez, P. Martinez, M. A. Diaz Castellanos, G. Sevilla, J. Garnacho-Montero, R. Hinojosa, E. Fernandez, A. Loza, C. Leon, A. Arenzana, D. Ocana, I. Navarrete, M. Zaheri Beryanaki, I. Sanchez, M. L. Avellanas, A. Lander, S. G. Ramirez de Arellano, M. I. Marquina Lacueva, P. Luque, I. Gonzalez, J. M. {a. } Monton, P. Dorado Regil, L. Iglesias, C. Pascual Gonzalez, Quiroga, A. Garcia-Rodriguez, L. Socias, P. Ibanez, M. Borges-Sa, A. Socias, A. Del Castillo, R. Jorda Marcos, J. M. Bonell, I. Amestaran, S. Ruiz-Santana, J. J. Diaz, Sison, D. Hernandez, A. Trujillo, L. Regalado, L. Lorente, M. Martin, S. Martinez, J. J. Caceres, B. Suberviola, P. Ugarte, F. Garcia-Lopez, A. Alvaro Alonso, A. Pasilla, M. {a. } L. Gomez Grande, A. Albaya, A. Canabal, L. Marina, A. Simon, J. Maria Anon, J. B. Lopez Messa, M. {a. } J. Lopez Pueyo, Z. Ferreras, S. Macias, J. Angel Berezo, J. B. Varela, A. A. Ojeda, A. A. Terrero, F. Tena Ezpeleta, Z. Paez, A. Garcia, R. M. {a. } Catalan, M. Ferrer, A. Torres, S. Barbadillo, L. Cabre, A. Rovira, F. Alvarez-Lerma, A. Vazquez, J. Nolla, F. Fernandez, J. R. Cervello, R. Manez, J. Ballus, R. M. {a. } Granada, J. Valles, M. Ortiz, C. Guia, F. Armestar, J. Paez, J. Almirall, X. Balanzo, J. Rello, E. Arnau, L. Llopart, M. Palomar, I. Catalan, J. M. {a. } Sirvent, C. Ferri, N. L. de Arbina, M. Badia, M. Valverdu-Vidal, F. Barcenilla, M. Magret, M. F. Esteban, J. Luna, J. M. {a. } Nava, J. G. de Molina, Z. Josic, F. Gurri, A. Rodriguez, T. Lisboa, D. de Mendoza, S. Trefler, R. Maria Diaz, E. Mesalles, J.-N. Jose, A. Fernandez-Zapata, T. Recio, A. Arrascaeta, M. {a. } J. Garcia-Ramos, E. Gallego, F. Bueno, M. Diaz, M. {a. } L. Cordero, J. A. Pastor, L. Alvarez-Rocha, D. Vila, A. D. Lamas, J. B. Perez, M. Ortiz Piquer, E. Merayo, V. J. Lopez-Ciudad, J. Cortez, E. Vilaboy, E. M. Saborido, R. J. Gonzalez, S. Freita, A. M. Lopez, J. Canabal, E. Ferres, J. L. Monzon, F. Goni, F. Del Nogal Saez, M. Blasco Navalpotro, M. {a. } C. Garcia-Torrejon, C. Perez-Calvo, D. Lopez, L. Arnaiz, S. Sanchez-Alonso, C. Velayos, F. del Rio, M. A. Gonzalez, M. C. Martin, J. M. {a. } Molina, J. C. Montejo, M. Catalan, P. Albert, A. de Pablo, J. E. Guerrero, J. B. Peyrat, E. Cerda, M. Alvarez, C. Pey, M. Rodriguez, E. Palencia, R. Caballero, C. Vaquero, F. Mariscal, S. Garcia, N. Carrasco, I. Prieto, A. Lietor, R. Ramos, B. Galvan, J. C. Figueira, M. C. Soriano, P. Galdos, B. Balandin Moreno, F. del Cabo, C. Hermosa, F. Gordo, A. Algora, A. Paredes, J. A. Cambronero, S. Gomez-Rosado, L. M. Prado Lopez, S. Martinez, F. F. Abad, M. Martinez, S. M. Buti, B. Gil Rueda, F. Garcia, L. Macaya, E. Maravi-Poma, I. Jimenez Urra, L. Macaya Redin, A. Telleria, J. Insansti, N. Gonzalez, P. Marco, L. Vidaur, B. Santamaria, J. C. Vergara, J. R. Iruretagoyena Amiano, A. Manzano, C. C. Arenal, P. M. Olaechea, J. Blanquer, R. Reig Valero, A. Belenger, S. Altaba, B. Alvarez-Sanchez, S. Alberto Picos, A. Sanchez-Miralles, J. Bonastre, M. Palamo, J. Cebrian, J. Cunat, B. Romero, R. Zaragoza, V. Paricio, A. Marques, S. Sanchez-Morcillo, S. Tormo, J. Latour, M. Angel Garcia & A. Ribas. (2011) Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. Journal of Antimicrobial Chemotherapy 66:5, pages 1140-1149.
Crossref
Crossref
R. Dutkowski. (2010) Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. Journal of Antimicrobial Chemotherapy 65:Supplement 2, pages ii11-ii24.
Crossref
Crossref
Alejandro Gómez-Gómez, Martin Magaña-Aquino, Christian A. García-Sepúlveda, Uciel R. Ochoa-Pérez, Reynaldo Falcón-Escobedo, Andreu Comas-García, Saray Aranda-Romo, Hugo I. Contreras-Treviño, Paulina V. Jiménez-Rico, Mario A. Banda-Barbosa, Félix Dominguez-Paulin, J. Mario Bernal-Blanco, Luis F. Pérez-González & Daniel E. Noyola. (2010) Severe Pneumonia Associated with Pandemic (H1N1) 2009 Outbreak, San Luis Potosí, Mexico. Emerging Infectious Diseases 16:1, pages 27-34.
Crossref
Crossref
Gerald V. Naccarelli, Helen Varker, Jay Lin & Kathy L. Schulman. (2009) Increasing Prevalence of Atrial Fibrillation and Flutter in the United States. The American Journal of Cardiology 104:11, pages 1534-1539.
Crossref
Crossref
Ashley Roberts & Joanne M. Langley. 2009. Evidence‐Based Infectious Diseases. Evidence‐Based Infectious Diseases
206
212
.
Christine C. Ginocchio, Madhavi Lotlikar, Leon Falk, Suman Arora, Margaret Kowerska, Mark Bornfreund & Ryhana Manji. (2009) Clinical performance of the 3M Rapid Detection Flu A+B Test compared to R-Mix culture, DFA and BinaxNOW Influenza A&B Test. Journal of Clinical Virology 45:2, pages 146-149.
Crossref
Crossref
Scott A. Harper, John S. Bradley, Janet A. Englund, Thomas M. File, Stefan Gravenstein, Frederick G. Hayden, Allison J. McGeer, Kathleen M. Neuzil, Andrew T. Pavia, Michael L. Tapper, Timothy M. Uyeki & Richard K. Zimmerman. (2009) Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clinical Infectious Diseases 48:8, pages 1003-1032.
Crossref
Crossref
Jeffrey A. Linder, Harry Reyes Nieva & William A. Blumentals. (2009) Antiviral and Antibiotic Prescribing for Influenza in Primary Care. Journal of General Internal Medicine 24:4, pages 504-510.
Crossref
Crossref
Sandra E. Talbird, Anita J. Brogan, Aleksander P. Winiarski & Beate Sander. (2009) Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States. American Journal of Health-System Pharmacy 66:5, pages 469-480.
Crossref
Crossref
S. Ward CasscellsElder GrangerAmii M. KressAndrea LintonMohammad MadjidLinda Cottrell. (2009) Use of Oseltamivir After Influenza Infection Is Associated With Reduced Incidence of Recurrent Adverse Cardiovascular Outcomes Among Military Health System Beneficiaries With Prior Cardiovascular Diseases. Circulation: Cardiovascular Quality and Outcomes 2:2, pages 108-115.
Crossref
Crossref
Suzanne E. Dale, Christine Mayer, Marie C. Mayer & Marilyn A. Menegus. (2008) Analytical and Clinical Sensitivity of the 3M Rapid Detection Influenza A+B Assay. Journal of Clinical Microbiology 46:11, pages 3804-3807.
Crossref
Crossref